Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FBGQ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,883
Award facts
- Contract value 100% obligated
- $15,882.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,882.78 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that supports global pharmaceutical procurement for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical supply vendor for the Defense Logistics Agency and other government healthcare systems. The contract reflects the company's established role in supplying specialty medications and pharmaceutical products to support military and veteran healthcare needs. This specific delivery order for Zepbound, an FDA-approved obesity treatment medication, aligns with the broader scope of the DLA Troop Support Medical prime vendor contract, which encompasses a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FBGQ9?
SPE2DB25FBGQ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FBGQ9 worth?
The government has obligated $15,883 on SPE2DB25FBGQ9.
Is contract SPE2DB25FBGQ9 an order under another contract?
Yes. SPE2DB25FBGQ9 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBGQ9 competed?
The extent of competition for SPE2DB25FBGQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award